Amgen To Present At Guggenheim Healthcare Talks Oncology Day

Rhea-AI Summary

Amgen (NASDAQ:AMGN) announced that Greg Friberg, its global oncology head, will participate in a fireside chat during the Guggenheim Healthcare Talks 2021 Oncology Day on February 12 at 12:30 p.m. ET. The live audio of the event will be available online for media, investors, and the public. Interested parties can access the webcast through Amgen's website, and it will be archived for 90 days post-event. Amgen is dedicated to developing innovative therapeutics for serious illnesses, focusing on high unmet medical needs and leveraging advanced human genetics.

THOUSAND OAKS, Calif., Feb. 9, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that Greg Friberg, vice president and global oncology therapeutic area head at Amgen, will participate in a fireside chat as part of the Guggenheim Healthcare Talks 2021 Oncology Day on Friday, Feb. 12 at 12:30 p.m. ET.

Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given at certain investor and medical conferences, can be accessed on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media) 
Arvind Sood, 805-447-1060 (investors) 

 

 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-guggenheim-healthcare-talks-oncology-day-301225263.html

SOURCE Amgen

FAQ

What is the date and time of Amgen's participation in the Guggenheim Healthcare Talks 2021?

Amgen will participate on February 12, 2021, at 12:30 p.m. ET.

Who is representing Amgen at the Guggenheim Healthcare Talks?

Greg Friberg, vice president and global oncology therapeutic area head, will represent Amgen.

How can I access the webcast of Amgen's presentation?

The webcast can be accessed on Amgen's website under the Investors section.

Will the Amgen fireside chat be available for replay?

Yes, the webcast will be archived and available for replay for at least 90 days.

What is Amgen's focus in biopharmaceuticals?

Amgen is committed to developing innovative therapeutics for serious illnesses, emphasizing high unmet medical needs.